TechCare: Mobile-AssessmenT and ThErapy for PsyCHosis: An Intervention for Clients Within the EArly InteRvention SErvice
- Conditions
- Feasibility Studies
- Interventions
- Other: TechCare
- Registration Number
- NCT02439619
- Lead Sponsor
- Lancashire Care NHS Foundation Trust
- Brief Summary
The aim of the project is to conduct a feasibility study of the mobile phone application "TechCare" for individuals with psychosis in the North West of England.
- Detailed Description
This feasibility study will follow the NIHR guidance on feasibility study design (NIHR, 2014) and will consist of both qualitative and quantitative components. The study will run across three strands as follows 1) Qualitative work \& Systematic review 2) Test run and Intervention refinement 3) Feasibility trial.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 16
- Each client must be accepted into the Psychosis Group of the Lancashire Early Intervention Service.
- Ages 18 - 35 years
- Medication stable for previous two months
- Clients must be currently stable-The Lancashire Early Intervention Team uses a traffic light system to indicate current symptomatology and risks of each client. For this study we will use only clients with a Green Light, signifying that they are currently stable.
- A score of 3 or more on positive symptoms on the PANSS
- Minimum score of 1 on the Calgary depression scale.
- Drug induced psychosis
- An acquired brain injury or learning disability
- Clients who are undergoing assessment, not formally diagnosed and accepted into the service.
- Lacking capacity for informed consent.
- Ultra High Risk of Developing Psychosis Group (i.e. Prodromal, not first episode)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Feasibility Trial TechCare -
- Primary Outcome Measures
Name Time Method Feasibility and Acceptability 36 months We will measure feasibility and acceptability by exploring whether appropriate individuals can be identified and recruited to an open trial of TechCare; whether TechCare is an acceptable intervention for individuals with psychosis and what measures will be important for assessing the impact of TechCare on delusions and low mood in psychosis.
- Secondary Outcome Measures
Name Time Method Psychopathology on The Positive and Negative Syndrome Scale (PANSS) 24 months The 30- item PANSS, is a clinician administered 30 item semi structured interview which provides balanced representation of positive symptoms and negative symptoms and gauges their relationship to one another and to global/general psychopathology
Psychopathology on The Psychotic Symptom Rating Scales (PSYRATS) 24 months The PSYRATS is a semi-structured interview measuring dimensions of delusions and hallucinations.
Satisfaction with CBT therapy on the CHoice of Outcome In Cbt for psychosEs 24 months This is an outcome measure which reflects the aims of cognitive behavioural therapy for psychosis and the priorities of service users.
Mental wellbeing on the Warwick-Edinburgh Mental Well Being Scale (WEMWBS) 24 months The WEMWBS is a measure of mental wellbeing which focuses entirely on positive aspects of mental health.
Measure of core beliefs regarding self and others on the Brief Core Schema Scale 24 months This is a 24 item measure of core beliefs regarding self and others. It is a nine item scale which allows for the quantitative and subjective dimension of depression in schizophrenia.
Depression on the Calgary depression scale 24 months The CDS was developed to measure the level of depression in schizophrenia. It is a nine item scale which allows for the quantitative and subjective dimension of depression in schizophrenia.
Work and social functioning on The Work and Social Adjustment Scale 24 months This is a five item measure of perceived impairment in five areas: work, home management, social life, private leisure and relationships
Quality of life on the EuroQoL-5 Dimensions EQ5-D 24 months the measure is standardised instrument looking at quality of life across five health domains (mobility, self-care, usual activities, pain/discomfort and anxiety/depression).
Trial Locations
- Locations (1)
Lancashire Care NHS Foundation Trust
🇬🇧Preston, Lancashire, United Kingdom